DSE yields 357.85% · PFE yields 6.20%● Live data
📍 DSE pulled ahead of the other in Year 1
Combined, DSE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DSE + PFE for your $10,000?
Duff & Phelps Select MLP and Midstream Energy Fund Inc. (the Fund), formerly Duff & Phelps Select Energy MLP Fund Inc., is a non-diversified, closed-end management investment company. The Fund invests at least 80% of its managed assets in energy master limited partnerships (MLPs) and midstream energy companies that are not organized as MLPs. The Fund may invest up to 20% of its managed assets in securities of issuers either in the energy sector and that are not MLPs or that produce products that are primarily for the use of companies in the energy sector (such as sand miners, certain chemical companies and coking coal processors). The Fund invests in midstream energy companies that includes entities that gather, process, market and transport energy assets, such as crude oil, natural gas, refined products, and natural gas liquids. Virtus Alternative Investment Advisers, Inc. is the investment advisor to the Fund. Duff & Phelps Investment Management Co. is the sub advisor for the Fund.
Full DSE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.